IT8948254A0 - 2-(n-acil)ammino-6,7-dimetossi tetraline, procedimento per la loro preparazione e composizioni farmaceutiche ad attivita' antiipertensiva che le contengono - Google Patents

2-(n-acil)ammino-6,7-dimetossi tetraline, procedimento per la loro preparazione e composizioni farmaceutiche ad attivita' antiipertensiva che le contengono

Info

Publication number
IT8948254A0
IT8948254A0 IT8948254A IT4825489A IT8948254A0 IT 8948254 A0 IT8948254 A0 IT 8948254A0 IT 8948254 A IT8948254 A IT 8948254A IT 4825489 A IT4825489 A IT 4825489A IT 8948254 A0 IT8948254 A0 IT 8948254A0
Authority
IT
Italy
Prior art keywords
tetralines
acil
dimethoxy
amino
procedure
Prior art date
Application number
IT8948254A
Other languages
English (en)
Other versions
IT1232160B (it
Inventor
Carla Franceschelli
Massimo Castorina
Mauro Marzi
Maria Ornella Tinti
Licia Pacifici
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of IT8948254A0 publication Critical patent/IT8948254A0/it
Priority to IT8948254A priority Critical patent/IT1232160B/it
Priority to EP90830347A priority patent/EP0412061B1/en
Priority to DE69013101T priority patent/DE69013101T2/de
Priority to AT90830347T priority patent/ATE112550T1/de
Priority to ES90830347T priority patent/ES2062492T3/es
Priority to DK90830347.2T priority patent/DK0412061T3/da
Priority to US07/559,052 priority patent/US5053424A/en
Priority to JP2203746A priority patent/JP2806608B2/ja
Application granted granted Critical
Publication of IT1232160B publication Critical patent/IT1232160B/it
Priority to HK98104931A priority patent/HK1005857A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043Leu-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • C07K5/06156Dipeptides with the first amino acid being heterocyclic and Trp-amino acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
IT8948254A 1989-07-31 1989-07-31 2-(n-acil)ammino-6,7-dimetossi tetraline, procedimento per la loro preparazione e composizioni farmaceutiche ad attivita' antiipertensiva che le contengono IT1232160B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IT8948254A IT1232160B (it) 1989-07-31 1989-07-31 2-(n-acil)ammino-6,7-dimetossi tetraline, procedimento per la loro preparazione e composizioni farmaceutiche ad attivita' antiipertensiva che le contengono
ES90830347T ES2062492T3 (es) 1989-07-31 1990-07-26 2-(n-acil)amino-6,7-dimetoxi tetralinas, procedimiento para su preparacion y composiciones farmaceuticas con actividad antihipertensiva que las contienen.
DE69013101T DE69013101T2 (de) 1989-07-31 1990-07-26 2-(N-acyl)amino-6,7-dimethoxytetraline, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen mit antihypertensiver Wirkung, die diese enthalten.
AT90830347T ATE112550T1 (de) 1989-07-31 1990-07-26 2-(n-acyl)amino-6,7-dimethoxytetraline, verfahren zu deren herstellung und pharmazeutische zusammensetzungen mit antihypertensiver wirkung, die diese enthalten.
EP90830347A EP0412061B1 (en) 1989-07-31 1990-07-26 2-(N-acyl)amino-6,7-dimethoxy tetralines, process for their preparation and pharmaceutical compositions having antihypertensive activity containing same
DK90830347.2T DK0412061T3 (da) 1989-07-31 1990-07-26 2-(N-acyl)amino-6,7-dimethoxytetraliner, fremgangsmåde til fremstilling heraf og farmaceutiske præparater med antihypertensiv aktivitet indeholdende disse
US07/559,052 US5053424A (en) 1989-07-31 1990-07-30 2-(n-acyl)amino-6,7-dimethoxy tetralines, and pharmaceutical compositions having antihypertensive activity containing same
JP2203746A JP2806608B2 (ja) 1989-07-31 1990-07-30 2―(n―アシル)アミノ―6,7―ジメトキシテトラリン、製法および抗高血圧剤
HK98104931A HK1005857A1 (en) 1989-07-31 1998-06-05 2-(n-acyl)amino-6,7-dimethoxy tetralines, process for their preparation and pharmaceutical compositions having antihypertensive activity containing same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8948254A IT1232160B (it) 1989-07-31 1989-07-31 2-(n-acil)ammino-6,7-dimetossi tetraline, procedimento per la loro preparazione e composizioni farmaceutiche ad attivita' antiipertensiva che le contengono

Publications (2)

Publication Number Publication Date
IT8948254A0 true IT8948254A0 (it) 1989-07-31
IT1232160B IT1232160B (it) 1992-01-25

Family

ID=11265513

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8948254A IT1232160B (it) 1989-07-31 1989-07-31 2-(n-acil)ammino-6,7-dimetossi tetraline, procedimento per la loro preparazione e composizioni farmaceutiche ad attivita' antiipertensiva che le contengono

Country Status (9)

Country Link
US (1) US5053424A (it)
EP (1) EP0412061B1 (it)
JP (1) JP2806608B2 (it)
AT (1) ATE112550T1 (it)
DE (1) DE69013101T2 (it)
DK (1) DK0412061T3 (it)
ES (1) ES2062492T3 (it)
HK (1) HK1005857A1 (it)
IT (1) IT1232160B (it)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3981872A (en) * 1972-10-06 1976-09-21 A. Christiaens Societe Anonyme Derivatives of 2-amino-(1,2,3,4-tetrahydronaphthalene)
AU543804B2 (en) * 1980-10-31 1985-05-02 Takeda Chemical Industries Ltd. Amides having bicyclic substituents on nitrogen
IL65501A (en) * 1981-05-08 1986-04-29 Astra Laekemedel Ab 1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them
CA1261855A (en) * 1986-04-11 1989-09-26 Alenka Paquet Derivatives of d-amino acids having anti-microbial properties

Also Published As

Publication number Publication date
US5053424A (en) 1991-10-01
JPH03178955A (ja) 1991-08-02
EP0412061A3 (en) 1991-08-14
IT1232160B (it) 1992-01-25
HK1005857A1 (en) 1999-01-29
EP0412061B1 (en) 1994-10-05
DE69013101D1 (de) 1994-11-10
DK0412061T3 (da) 1994-10-31
ATE112550T1 (de) 1994-10-15
JP2806608B2 (ja) 1998-09-30
ES2062492T3 (es) 1994-12-16
EP0412061A2 (en) 1991-02-06
DE69013101T2 (de) 1995-02-23

Similar Documents

Publication Publication Date Title
IT8919193A0 (it) Derivati imidazolonici ad attivita' antiipertensiva, loro metodi di preparazione e composizioni farmaceutiche che li contengono.
IT1203647B (it) Uree e tiouree sostituite aventi attivita' antiaterosclerotica,procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IT9020020A0 (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
IT8922246A0 (it) Procedimento di preparazione di 3-ciano-3,5,5'-trimetil-1-cicloesanone
ITMI932193A0 (it) Composti ad attivita' antiistaminica per la loro preparazione e composizioni farmaceutiche che li contengono
IT8219486A0 (it) Nuovi composti ad attivita'antiinfiammatoria, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT8221678A0 (it) Esteri basici ad attivita'calcioantagonista, procedimenti per la loro preparazione e relative composizioni farmaceutiche.
IT8320468A0 (it) Nuovi composti ad attivita'antiinfiammatoria, procedimento per la loro preparazione e composizioni farmaceutiche che licontengono.
IT8648779A0 (it) N-alchil derivati della 2-ammino-6,7-dimetossi tetralina,procedimenti per la loro preparazione e composizioni farmaceutiche ad attivita' antiipertensiva che li contengono
IT9047551A0 (it) Impiego di a-amminofluorochetoni per la preparazione di medicamenti ad attivita' cardiovascolare e antipertensiva.
IT8920996A0 (it) Derivati di 2 ammino 1,2,3,4 tetraidronaftalene ad attivita' cardiovascolare, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT8847609A0 (it) -2-n-alchil,n-metlciclopropil-ammino-6,7 dimetossi tetraline, procedimento per la loro preparazione e composizioni farmaceutiche ad attivita' antiipertensiva che le contengono
IT1167746B (it) Nitroimidazoli ad attivita' tricomonacida, procedimento per la loro preparazione e relative composizioni farmaceutiche
IT1243702B (it) Composti ad attivita' nootropa, procedimento per la loro preparazione e relative composizioni farmaceutiche
IT8847652A0 (it) Derivati della 2-ammino-6-7-dimetossi tetralina, procedimento per la loro preparazione e composizioni farmaceutiche ad attivita'antiipertensiva che le contengono.
IT8747852A0 (it) Benzammidi sostituite, procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
ITMI911335A1 (it) Composti ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI911298A1 (it) Composti ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT8519975A0 (it) Composti ad attivita'antiinfiammatoria, procedimento per la loro preparazione e composizioni farmaceutiche che licontengono.
IT8921961A0 (it) Metodo per l'ottenimento di silibinina e composizioni farmaceutiche che contengono la stessa
IT8520240A0 (it) Composti ad attivita'cardiovascolare, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT8520432A0 (it) La loro preparazione e composti ad attivita'composizioni farmaceutiche che li antiinfiammatoria, procedimento per contengono.
IT8221679A0 (it) Composti idrossiminici e alcossiminici ad attivita'calcioantagonista, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT8321043A0 (it) Esteri basici ad attivita'calcioantagonista, procedimenti per la loro preparazione e relative composizioni farmaceutiche.
IT8820927A0 (it) Composto ad attivita'antiinfiammatoria, procedimento per la sua preparazione e relative composizioni farmaceutiche.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970609